Senza DRG, i pazienti non hanno accesso a farmaci e monitoraggio
Risultati per: Un farmaco per il diabete potrebbe curare l’Alzheimer.
Questo è quello che abbiamo trovato per te
Diabetologi, riconoscere come malattia il diabete 1 asintomatico
Senza DRG, i pazienti non hanno accesso a farmaci e monitoraggio
Alzheimer, Irccs S. Raffaele è diventato un centro ricerca e diagnosi precoce
Focus anche sul trattamento innovativo e riabilitativo
Ok Ue a farmaco anti-Alzheimer, il primo a rallentare malattia
Neurologi: ‘si apre una nuova storia per i pazienti’
Diabete, le nuove tecnologie rivoluzionano la gestione: sensori, microinfusori e pancreas artificiali
I moderni dispositivi permettono di adattare la terapia insulinica alle esigenze individuali di ciascun paziente, migliorando l’efficacia del trattamento
Diabete tipo 1, screening bimbi riduce 94% rischio complicanze
Cherubini (Siedp) “evitabili in oltre 450 bimbi ogni anno”
Abstract 4147625: Cardiometabolic Syndrome and Incident Alzheimer’s Disease: The Predicative Value of Age and CMS Using Cox and Machine Learning Models
Circulation, Volume 150, Issue Suppl_1, Page A4147625-A4147625, November 12, 2024. Background:Cardiometabolic syndrome (CMS) poses a significant public health concern. The study aimed to investigate the predictive value of age and CMS for incident Alzheimer’s disease (AD) in women aged≥50.Methods:A cohort of women aged 50-79 (n= 63,117) who participated in the Women’s Health Initiative Observational Study (WHIOS) in 1993-1998, without baseline AD and followed through to March 1, 2019, were analyzed. CMS was defined as having ≥3 of five CMS components: large waist circumference, HBP, elevated triglycerides, elevated glucose, and low HDL-cholesterol. AD was classified by physician-diagnoses of incident AD. Hazards ratios (HR) of AD risk associated with CMS by age were analyzed using Cox’s proportional hazards regression analysis. Machine learning (ML)-XGBoost and Lasso Cox models clustered individuals with low, mild, moderate, and severe risk of incident AD.Results:During a median follow-up of 20 years (range: 3.36 to 23.36 years), 8340 developed incident AD. The incident rate (95%CI) of AD was 8.6 (8.1-9.1) per 1000 person-years (PY) in women with CMS, and 7.0 (6.9-7.2) per 1000 PY in those without CMS (p
Abstract 4136600: Hypertensive disorders of pregnancy and the risk of Dementia, Alzheimer’s disease, and Vascular Dementia. A Systematic review and Meta-analysis of 25,03,538 women participants.
Circulation, Volume 150, Issue Suppl_1, Page A4136600-A4136600, November 12, 2024. Background:Hypertensive disorders of pregnancy (HDP) are associated with maternal adverse cardiovascular outcomes. However, their association with maternal Dementia and Alzheimer’s disease is not well established with limited and conflicting results to date.Objective:We sought to evaluate the association between HDP and risk of incidence of Dementia, and Alzheimer’s disease.Methods:We performed a systematic review and meta-analysis of available literature that enrolled women with HDP and women without HDP groups. PubMed, Embase and ClinicalTrials.gov were systematically searched from inspection till May 2024 without any language restrictions. Adjusted hazard ratios (aHR) and 95% confidence intervals (CI) were pooled using a random-effect model.Results:A total of 8 studies with 2503538 patients (1,51,905 in women with HDP and 23,51,633 in the women without HDP group) were included. Pooled analysis shows that HDP women were having 37% higher risk of dementia (aHR, 1.37(95%CI: 1.27-1.46), P
Tumore al seno, nuovo farmaco blocca metastasi in animali
In Italia 37mila persone con cancro metastatico della mammella
Riviste le linee guida diagnostiche per l’Alzheimer
Alzheimer, vari tipi di vaccini abbassano i rischi anche del 30-40%
Aiutano a ‘ripulire’ accumuli tossici nel cervello
La terapia del diabete mellito di tipo 1
Alzheimer, una pdl per riconoscere e tutelare i caregiver
Lions italiani hanno contribuito a proposta con gruppo di lavoro
Multa Ue da 462 milioni a Teva, 'abuso su farmaco sclerosi'
‘La società ha abusato del brevetto ostacolando una cura rivale’
Uno studio per superare la farmaco resistenza nel tumore al seno
Ricerca del Cro di Aviano pubblicata sul Journal of Pathology
Uno studio per superare la farmaco resistenza nel tumore al seno
Ricerca del Cro di Aviano pubblicata sul Journal of Pathology